Relationship between endoscopic mucosal healing and histologic inflammation during remission maintenance phase in ulcerative colitis: a retrospective study

被引:29
作者
Kanazawa, Mimari [1 ]
Takahashi, Fumiaki [1 ,2 ]
Tominaga, Keiichi [1 ]
Abe, Keiichiro [1 ]
Izawa, Naoya [1 ]
Fukushi, Koh [1 ]
Nagashima, Kazunori [1 ]
Kanamori, Akira [1 ]
Takenaka, Kazuhiro [1 ]
Sugaya, Takeshi [1 ]
Iijima, Makoto [1 ]
Takada, Atsuko [3 ]
Imai, Yasuo [3 ]
Hiraishi, Hideyuki [1 ]
Irisawa, Atsushi [1 ]
机构
[1] Dokkyo Med Univ, Dept Gastroenterol, 880 Kitakobayashi, Shimotsuga, Tochigi 3210293, Japan
[2] Japanese Red Cross Ashikaga Hosp, Dept Internal Med, Ashikaga, Tochigi, Japan
[3] Dokkyo Med Univ, Dept Diagnost Pathol, Shimotsuga, Tochigi, Japan
关键词
QUALITY-OF-LIFE; BOWEL-DISEASE; 5-AMINOSALICYLIC ACID; PRACTICE GUIDELINES; CLINICAL RELAPSE; RISK-FACTOR; THERAPY; BIOPSY; MESALAZINE; INFLIXIMAB;
D O I
10.1055/a-0869-7619
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and study aims Recently, histological inflammation has been suggested to be an important predictor of sustained remission or relapse of ulcerative colitis (UC). In this study, we retrospectively compared severity of histological inflammation with endoscopic findings in UC patients with mucosal healing (MH) in the remission maintenance phase, and investigated whether histological healing could be a predictor of sustained remission. Patients and methods This study included 166 patients with MH in the remission maintenance phase. Endoscopic evaluation was based on the Mayo endoscopic subscore (MES), and MH was defined as MES 0 or 1. Severity of histological inflammation was graded according to the Matts classification. Patients with Matts 1 and 2 were included in the histological healing (HH) group, and those with Matts 3, 4, and 5, in the non-histological healing (NHH) group.In patients with MH, incidence of relapse was compared and analyzed according to severity of histological inflammation. Results The remission maintenance rate was significantly higher in the MES 0 group than in the MES 1 group ( P =0.004). The rate was significantly higher in the HH group than in the NHH group ( P =0.003). Within the MES 1 group, the rate was significantly higher in the HH subgroup than in the NHH subgroup ( P =0.030). Conclusions This retrospective study suggests that histological healing can be a predictor of sustained remission in UC patients, and examination of histological inflammation provides useful information for long-term management of UC, particularly in patients with MES 1.
引用
收藏
页码:E568 / E575
页数:8
相关论文
共 21 条
  • [11] Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis
    Yokoyama, Kaoru
    Kobayashi, Kiyonori
    Mukae, Miyuki
    Sada, Miwa
    Koizumi, Wasaburo
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2013, 2013
  • [12] Prostaglandin E-major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase
    Sakurai, Toshiyuki
    Akita, Yoshihiro
    Miyashita, Haruna
    Miyazaki, Ryosuke
    Maruyama, Yuki
    Saito, Tomoko
    Shimada, Mariko
    Yamasaki, Takuji
    Arhihiro, Seiji
    Kato, Tomohiro
    Matsuura, Tomokazu
    Ikegami, Masahiro
    Okayasu, Isao
    Saruta, Masayuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (05) : 847 - 854
  • [13] Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing
    Yamamoto, Takayuki
    Shimoyama, Takahiro
    Umegae, Satoru
    Matsumoto, Koichi
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
  • [14] Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study
    Pugliese, Daniela
    Aratari, Annalisa
    Festa, Stefano
    Ferraro, Pietro Manuel
    Monterubbianesi, Rita
    Guidi, Luisa
    Scribano, Maria Lia
    Papi, Claudio
    Armuzzi, Alessandro
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [15] PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system
    Gui, Xianyong
    Bazarova, Alina
    Del Amor, Rocio
    Vieth, Michael
    de Hertogh, Gert
    Villanacci, Vincenzo
    Zardo, Davide
    Parigi, Tommaso Lorenzo
    Royset, Elin Synnove
    Shivaji, Uday N.
    Monica, Melissa Anna Teresa
    Mandelli, Giulio
    Bhandari, Pradeep
    Danese, Silvio
    Ferraz, Jose G.
    Hayee, Bu'Hussain
    Lazarev, Mark
    Parra-Blanco, Adolfo
    Pastorelli, Luca
    Panaccione, Remo
    Rath, Timo
    Tontini, Gian Eugenio
    Kiesslich, Ralf
    Bisschops, Raf
    Grisan, Enrico
    Naranjo, Valery
    Ghosh, Subrata
    Iacucci, Marietta
    GUT, 2022, 71 (05) : 889 - 898
  • [16] Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study
    Lee, Jin
    Park, Su Bum
    Kim, Hyung Wook
    Lee, Hong Sub
    Jee, Sam Ryong
    Lee, Jong Hun
    Kim, Tae Oh
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2022, 2022
  • [17] Intestinal Ultrasound, Fecal Calprotectin, and Their Combination to Predict Endoscopic Mucosal Healing in Ulcerative Colitis: A Real-Life Cross-Sectional Study
    Yzet, Clara
    Meudjo, Erica
    Brazier, Franck
    Hautefeuille, Vincent
    Moreau, Capucine
    Robert, Camille
    Decrombecque, Catherine
    Sarba, Ruxandra
    Pichois, Raphael
    Richard, Nicolas
    Meynier, Jonathan
    Fumery, Mathurin
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [18] Relationship between the prognosis of periodontitis and occlusal force during the maintenance phase - a cohort study
    Takeuchi, N.
    Ekuni, D.
    Yamamoto, T.
    Morita, M.
    JOURNAL OF PERIODONTAL RESEARCH, 2010, 45 (05) : 612 - 617
  • [19] Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study
    Naganuma, Makoto
    Aoyama, Nobuo
    Tada, Tomohiro
    Kobayashi, Kiyonori
    Hirai, Fumihito
    Watanabe, Kenji
    Watanabe, Mamoru
    Hibi, Toshifumi
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (04) : 494 - 506
  • [20] Relationship between non-adherence to aminosalicylate medication and the risk of clinical relapse among Japanese patients with ulcerative colitis in clinical remission: a prospective cohort study
    Kawakami, Aki
    Tanaka, Makoto
    Nishigaki, Masakazu
    Naganuma, Makoto
    Iwao, Yasushi
    Hibi, Toshifumi
    Sanada, Hiromi
    Yamamoto-Mitani, Noriko
    Kazuma, Keiko
    JOURNAL OF GASTROENTEROLOGY, 2013, 48 (09) : 1006 - 1015